Hansa Biopharma to host conference call to provide interim r

/PRNewswire/ -- Hansa Biopharma AB (NASDAQ Stockholm: HNSA) will publish its interim report for January-September 2022 at 8:00 CET on October 20, 2022. All...

Related Keywords

United States , Copenhagen , Køavn , Denmark , Stockholm , Sweden , United Kingdom , Gothenburg , Vastra Gotalands Lan , Tulstrup , Hovedstaden , Oslo , Norway , San Francisco , California , American , Hansa Biopharma , Prnewswire Hansa Biopharma , Klaus Sindahl , Donato Spota , Bryan Garnier , Health Care , Interim Report , Redeye After Work , Redeye Lunch , Ugebrev Life Science Conference , Redeye Life Science Day , Erik Penser Banks Temadag , Nordic American Life Science Conference , Healthcare Conference , Carnegie Nordic Healthcare Seminar , Nasdaq Stockholm , Hansa Biopharma Ab , Health Care Amp Hospitals , Medical Pharmaceuticals , Biotechnology , Automotive , Transportation , Rucking Amp Railroad , Conference Call Announcements , Accounting News Amp Issues ,